Related Experiment Video
Updated: Jul 6, 2026
13:09
Segmentation and Measurement of Fat Volumes in Murine Obesity Models Using X-ray Computed Tomography
Published on: April 4, 2012
Summary
Obesity is a widespread health issue in Europe, linked to serious diseases and reduced life expectancy. This study examines the significant health and economic impacts of obesity and its comorbidities.
Area of Science:
- Public Health
- Epidemiology
- Cardiovascular Disease
Background:
- Obesity prevalence in Europe mirrors other industrialized regions.
- Obesity-related diseases (hypertension, hyperlipidemia, diabetes, hyperuricemia) pose significant public health and economic challenges.
- Existing research indicates a negative impact of obesity on life expectancy.
Purpose of the Study:
- To analyze the prevalence and impact of obesity in Europe.
- To discuss the association between obesity, related diseases, and life expectancy.
- To critically evaluate divergent findings regarding obesity's effect on longevity.
Main Methods:
- Review of prospective studies from Scandinavia.
- Critical discussion of data from the Seven Countries Study.
- Analysis of epidemiological trends in obesity and related diseases.
Main Results:
- Obesity and associated conditions are prevalent in Europe.
- Evidence suggests obesity contributes to a reduced lifespan.
- Discrepancies exist in study findings on obesity's impact on life expectancy.
Conclusions:
- Obesity represents a major health concern in Europe with substantial economic implications.
- Further investigation is needed to reconcile divergent findings on obesity's effect on life expectancy.
- Public health strategies addressing obesity are crucial for improving longevity and reducing healthcare costs.
Related Concept Videos
01:02Hypodermis
The hypodermis (the subcutaneous layer or superficial fascia) is present directly below the dermis. It connects the skin to the underlying fascia (fibrous tissue) of the bones and muscles. It is not strictly a part of the skin, although the border between the hypodermis and dermis can be difficult to distinguish. The hypodermis consists of well-vascularized, loose, areolar connective tissue and adipose tissue, which functions as a mode of fat storage and provides insulation and cushioning for...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:23Binge Eating Disorders
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...